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Purpose.  
Our hypothesis predicts that retinal blood vessels increase in density during early-stage 
progression to moderate nonproliferative diabetic retinopathy (NPDR). The renin-angiotensin 
system (RAS) is implicated in the pathogenesis of DR and in the function of circulating 
angiogenic cells (CACs), a critical bone marrow-derived population that is instrumental in 
vascular repair.  
Methods.  
Arterial and venous patterns extracted from images of 6 normal controls and 3 early NPDR 
subjects (2 moderate, 1 mild) by Spectralis® OCT following fluorescein angiography (FA) were  
mapped by NASA’s VESsel GENeration Analysis (VESGEN) software to yield branching 
generations (Gx) quantified by parameters that include densities of vessel length (Lv), area (Av) 
and number (Nv). Peripheral blood of diabetics and controls was collected for CD34+ CAC 
isolation. RAS gene expressions in CACs were measured by qPCR for Mas receptor for Ang-(1-
7). Vasoreparative function of CACs was assessed by migration ability toward CXCL12 (SDF-1) 
using QCM 5μM 96-well chemotaxis cell migration assay.  
Results.  
By VESGEN analysis, vessel density measured by Lv, Av, and Nv in early NPDR was greater than 
in control. For example, Lv was 2.00±0.06E-2 px/px2 in NPDR veins for all branching 
generations compared to 1.01±0.06E-2 px/px2 in control, and 1.64±0.13E-2 px/px2 compared to 
8.90±1.37E-3 px/px2 in arteries. Results were confirmed by other parameters such as Av and Nv. 
The expression of Mas in CACs was reduced in NPDR relative to control, indicating possible 
loss of compensation of the protective RAS at this stage of DR. NPDR was associated with 
CD34+ CAC migratory dysfunction toward CXCL12, which was corrected with Ang-(1-7) 
pretreatment prior to CXCL12 exposure.  
Conclusions.  
For our ongoing longitudinal study, preliminary evidence by VESGEN indicates that vascular 
density increased in early NPDR compared to control. If confirmed by more complete analysis, 
results are potentially of value for determining optimal therapies at early stages of NPDR, when 
regenerative vascular treatments are more likely to be successful. These data also suggest the 
protective RAS axis within diabetic CACs is lost early in DR and is associated with increased vascular 
remodeling evidenced by VESGEN analysis.    
https://ntrs.nasa.gov/search.jsp?R=20160005778 2019-08-29T17:53:34+00:00Z
  2 





Author Disclosure Information: none.  
